drugset / Trial / NCT01356472

Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia

NCT01356472 ↗

Phase 4 Unknown 60 enrolled Ruijin Hospital Pfizer · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

As previous studies showed that the synergy between linezolid and carbapenem in vitro and in vivo (animal studies), our study is aim to investigate the activity of linezolid, alone and in combination with carbapenem against methicillin-resistant Staphylococcus aureus (MRSA) in ventilator-associated pneumonia (VAP) patients.

Timeline

Start
2011-06
Primary completion
2013-06
Completion
—

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Imipenem/cilastatin Unknown — —